Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Anosmia and Ageusia in COVID-19
NCT04528329Phase 4Unknown
- Sponsor
- ClinAmygate
- Start
- Mar 2021
- Primary completion
- Nov 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4 trial of dexamethasone in coronavirus disease 2019 (COVID-19), anosmia and Ageusia (2 arms), sponsored by ClinAmygate. Primary endpoint: Time to recovery of Anosmia and / or ageusia at 6 weeks. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
coronavirus disease 2019 (COVID-19)anosmiaAgeusia
Beyond the preview
Go deeper on NCT04528329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04528329.